283. 後天性赤芽球癆 Acquired pure red cell aplasia Clinical trials / Disease details


臨床試験数 : 19 薬物数 : 36 - (DrugBank : 23) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05559827
(ClinicalTrials.gov)
September 202214/9/2022Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell TransplantationRandomized Prospective Trial Evaluating the Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell TransplantationImmunological Pure Red Cell AplasiaDrug: IsatuximabAssistance Publique - Hôpitaux de ParisNULLNot yet recruiting15 YearsN/AAll90Phase 2NULL